India's Cipla set to undercut rivals with generic remdesivir: Sources

Cipla India business CEO and executive vice president said in an emailed statement that the company was launching Cipremi commercially on Wednesday and aims to supply over 80,000 vials within the first month, but did not give details on pricing or dosage. The drug will be available through the government and hospitals only, the company said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Ocl6dT
via IFTTT